FDA says benefits outweigh risks for Pfizer/BioNTech COVID-19 vaccine in children

Go back to FDA says benefits outweigh risks for Pfizer/BioNTech COVID-19 vaccine in children

Pfizer (PFE) Covid Shot For Kids Age 5-11 Gets FDA Panel's Backing - Bloomberg

October 26, 2021 4:18 PM EDT

Pfizer (NYSE: PFE) Covid Shot For Kids Age 5-11 Gets FDA Panel's Backing - Bloomberg

... More